NEW YORK, April 30 (GenomeWeb News) - Bruker BioSciences announced at the close of market yesterday that it has closed its public offering of 17.3 million shares.

 

Of the shares, 3.5 million were sold by the company and 13.8 million by four stockholders related to CEO Frank Laukien. The stock was priced at $4.50 per share.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.